- Home
- ANIX vs ISPR Comparison
ANIX vs ISPR Comparison
Compare ANIX & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANIX | ISPR |
|---|---|---|
| Founded | 1982 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 99.1M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ANIX | ISPR |
|---|---|---|
| Price | $2.83 | $1.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.67 | $7.50 |
| AVG Volume (30 Days) | ★ 103.6K | 75.5K |
| Earning Date | 05-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.82 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $127,494,304.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.44 | $1.44 |
| 52 Week High | $5.46 | $3.87 |
Technical Indicators
Market Signals| Indicator | ANIX | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 53.40 | 47.48 |
| Support Level | $2.74 | $1.64 |
| Resistance Level | $3.10 | $2.04 |
| Average True Range (ATR) | 0.16 | 0.16 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 80.61 | 55.28 |
Price Performance
Historical ComparisonAbout ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.